Professor Dr Michael Quintel Joins Sphere’s Medical Advisory Board
News Jan 14, 2015
Sphere Medical has announced the appointment of Professor Dr Michael Quintel to its Medical Advisory Board (“MAB”). Professor Quintel is a leading clinician within the German and European intensive care profession who fully complements Sphere Medical’s current MAB members.
Sphere’s Medical Advisory Board draws together the wide-ranging medical expertise of its members to understand and address clinical needs, ultimately guiding Sphere’s clinical programme.
Leveraging extensive clinical experience within the intensive care setting, Professor Quintel will add both insight and support to the introduction of Sphere’s devices for the critical care environment, including the newly launched Proxima patient-dedicated blood gas analyzer.
Professor Quintel is the Director of the Department of Anaesthesiology, Emergency and Intensive Care Medicine at the University of Göttingen, Germany; a member of the European Society of Intensive Care Medicine (ESICM) group on respiratory failure; and member of the scientific committee of the ECMOnet.
In addition, he is past President of the German Interdisciplinary Society of Intensive Care Medicine (DIVI) and a past council member of the German Society of Anaesthesia and Intensive Care (DGAI). Professor Quintel is also a member of the German Sepsis Society and an Investigator in the SepNet Sepsis Clinical Trial Network in Germany, participating in numerous sepsis and critical care trials.
Professor Quintel will work alongside fellow MAB members - Professor Jean-Louis Vincent, Professor of Intensive Care at the Université Libre de Bruxelles and the Head of the Department of Intensive Care, Erasme University Hospital (University of Brussels) and Dr Tom Clutton-Brock, Head of Anaesthesia & Intensive Care at The University of Birmingham Medical School and Associate Medical Director at the University Hospital Birmingham NHS Foundation Trust.
Commenting on this appointment, Sphere Medical’s Chief Executive Officer, Wolfgang Rencken, said: “Professor Quintel’s appointment to Sphere Medical’s Medical Advisory Board will bring significant insight into the needs of intensive care clinicians which is essential as we introduce our new Proxima miniature blood gas analyzer to the European market. We look forward to drawing upon Dr Quintel’s extensive experience within the German intensive care profession, in particular, his work on sepsis, as this is one of the market segments we are initially focussing on.”
Professor Quintel added: “Proxima addresses some important issues in the management of unstable critically ill patients. I look forward to advising Sphere Medical on this exciting development in critical care.”
The CE marked Proxima system represents the next step on in blood gas point-of-care testing (POCT) as it is attached directly to the patient through their arterial line, in-series with the blood pressure transducer.
Without leaving the bedside, closed blood samples can be withdrawn frequently, analyzed and then returned directly to the patient. This enables rapid and frequent delivery of blood gas results to aid early decision making and closer control of therapy for critically ill patients, whilst also conserving blood and reducing nurse dependency - all of which will ultimately improve patient outcomes.